Molecular Cloning, Heterologous Expression, Purification, and Evaluation of Protein–Ligand Interactions of CYP51 of <i>Candida krusei</i> Azole-Resistant Fungal Strain

Molecular Cloning, Heterologous Expression, Purification, and Evaluation of Protein–Ligand Interactions of CYP51 of <i>Candida krusei</i> Azole-Resistant Fungal Strain

Due to the increasing prevalence of fungal diseases caused by fungi of the genus <i>Candida</i> and the development of pathogen resistance to available drugs, the need to find new effective antifungal agents has increased. Azole antifungals, which are inhibitors of sterol-14α-demethylase...

Full description

Bibliographic Details
Main Authors:	Tatsiana V. Tsybruk, Leonid A. Kaluzhskiy, Yuri V. Mezentsev, Tatyana N. Makarieva, Kseniya M. Tabakmaher, Natalia V. Ivanchina, Pavel S. Dmitrenok, Alexander V. Baranovsky, Andrei A. Gilep, Alexis S. Ivanov
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Biomedicines
Subjects:	lanosterol 14-alpha demethylase CYP51 cytochrome P450 azole inhibitors heterocyclic analogues of steroids marine steroids
Online Access:	https://www.mdpi.com/2227-9059/11/11/2873

Similar Items

Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens
by: Katharina Rosam, et al.
Published: (2020-12-01)

Insights into the Multi-Azole Resistance Profile in <i>Candida haemulonii</i> Species Complex
by: Laura Nunes Silva, et al.
Published: (2020-10-01)

Structural Insights into the Azole Resistance of the <i>Candida albicans</i> Darlington Strain Using <i>Saccharomyces cerevisiae</i> Lanosterol 14α-Demethylase as a Surrogate
by: Danyon O. Graham, et al.
Published: (2021-10-01)

Human Lanosterol 14-Alpha Demethylase (CYP51A1) Is a Putative Target for Natural Flavonoid Luteolin 7,3′-Disulfate
by: Leonid Kaluzhskiy, et al.
Published: (2021-04-01)

Chronic Disruption of the Late Cholesterol Synthesis Leads to Female-Prevalent Liver Cancer
by: Kaja Blagotinšek Cokan, et al.
Published: (2020-11-01)

Phytochemical profiling of Piper crocatum and its antifungal mechanism action as Lanosterol 14 alpha demethylase CYP51 inhibitor: a review [version 3; peer review: 2 approved]
by: Dadan Sumiarsa, et al.
Published: (2023-05-01)

Characterisation of <i>Candida parapsilosis</i> CYP51 as a Drug Target Using <i>Saccharomyces cerevisiae</i> as Host
by: Yasmeen N. Ruma, et al.
Published: (2022-01-01)

Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase
by: H. James Harwood, Jr., et al.
Published: (2005-03-01)

Identification of 1, 2, 4-Triazine and Its Derivatives Against Lanosterol 14-Demethylase (CYP51) Property of Candida albicans: Influence on the Development of New Antifungal Therapeutic Strategies
by: Abhishek Kumar Verma, et al.
Published: (2022-03-01)

Data on molecular docking of tautomers and enantiomers of ATTAF-1 and ATTAF-2 selectivty to the human/fungal lanosterol-14α-demethylase
by: Hamid Irannejad, et al.
Published: (2020-08-01)

Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases
by: Brian C. Monk, et al.
Published: (2021-01-01)

A Cyp51B Mutation Contributes to Azole Resistance in <i>Aspergillus fumigatus</i>
by: Irene Gonzalez-Jimenez, et al.
Published: (2020-11-01)

Point Mutations in the 14-α Sterol Demethylase Cyp51A or Cyp51C Could Contribute to Azole Resistance in <i>Aspergillus flavus</i>
by: Jose Lucio, et al.
Published: (2020-10-01)

Design, Synthesis, and Biological Activity of New Triazole and Nitro-Triazole Derivatives as Antifungal Agents
by: Hossein Sadeghpour, et al.
Published: (2017-07-01)

<i>CYP51</i> Mutations in the <i>Fusarium solani</i> Species Complex: First Clue to Understand the Low Susceptibility to Azoles of the Genus <i>Fusarium</i>
by: Pierre Vermeulen, et al.
Published: (2022-05-01)

Development of Thiazolidinones as Fungal Carbonic Anhydrase Inhibitors
by: Özlen Güzel-Akdemir, et al.
Published: (2020-04-01)

Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
by: Victor Marin, et al.
Published: (2020-07-01)

Profiling azole resistant haplotypes within Zymoseptoria tritici populations using nanopore sequencing
by: Yaiza Gutierrez Vazquez, et al.
Published: (2022-10-01)

Detection of Azole Drug Resistance of the Aspergillus Species Cyp51a Gene by PCR
by: Raksha, et al.
Published: (2019-06-01)

Uncovering New Mutations Conferring Azole Resistance in the Aspergillus fumigatus cyp51A Gene
by: Peiying Chen, et al.
Published: (2020-01-01)

First detection of Aspergillus fumigatus azole-resistant strain due to Cyp51A TR46/Y121F/T289A in an azole-naive patient in Spain
by: T. Pelaez, et al.
Published: (2015-07-01)

Azoles
by: İftihar KÖKSAL, et al.
Published: (2008-09-01)

A Novel Series of Acylhydrazones as Potential Anti-Candida Agents: Design, Synthesis, Biological Evaluation and In Silico Studies
by: Anca-Maria Borcea, et al.
Published: (2019-01-01)

Structure based approach for twin-enzyme targeted benzimidazolyl-1,2,4-triazole molecular hybrids as antifungal agents
by: Radha Ahuja, et al.
Published: (2020-06-01)

Comparative analysis of the biological characteristics and mechanisms of azole resistance of clinical Aspergillus fumigatus strains
by: Meng Zeng, et al.
Published: (2023-11-01)

Detecting Azole-Antifungal Resistance in <i>Aspergillus fumigatus</i> by Pyrosequencing
by: Mireille H. van der Torre, et al.
Published: (2020-01-01)

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
by: Jochem B. Buil, et al.
Published: (2018-08-01)

Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus
by: Scott eMoye-Rowley
Published: (2015-02-01)

Surveillance for Azole-Resistant Aspergillus fumigatus in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998–2017
by: Alireza Abdolrasouli, et al.
Published: (2018-09-01)

Application of MS-Based Metabolomic Approaches in Analysis of Starfish and Sea Cucumber Bioactive Compounds
by: Roman S. Popov, et al.
Published: (2022-05-01)

In silico prediction of ATTAF-1 and ATTAF-2 selectivity towards human/fungal lanosterol 14α-demethylase using molecular dynamic simulation and docking approaches
by: Hamid Irannejad, et al.
Published: (2020-01-01)

[Final accepted version, unedited] Understanding the Environmental Drivers of Clinical Azole Resistance in Aspergillus Spp.
by: Pooja Sen, et al.
Published: (2022-11-01)

Genetic and Phenotypic Characterization of in-Host Developed Azole-Resistant <i>Aspergillus flavus</i> Isolates
by: Jochem B. Buil, et al.
Published: (2021-02-01)

The Synthesis of Novel <i>aza</i>-Steroids and <i>α</i>, <i>β</i>-Unsaturated-Cyanoketone from Diosgenin
by: Dayana Mesa, et al.
Published: (2023-10-01)

Drimane Sesquiterpene Aldehydes Control <i>Candida</i> Yeast Isolated from Candidemia in Chilean Patients
by: Víctor Marín, et al.
Published: (2022-10-01)

Epidemiology and Azole Resistance of Clinical Isolates of Aspergillus fumigatus from a Large Tertiary Hospital in Ningxia, China
by: Kang Y, et al.
Published: (2024-02-01)

Effects of FoxO4 overexpression on cholesterol biosynthesis, triacylglycerol accumulation, and glucose uptake
by: Jun Zhu, et al.
Published: (2010-06-01)

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?
by: Tamara Zoran, et al.
Published: (2019-01-01)

Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS)1
by: K. Fon Tacer, et al.
Published: (2002-01-01)

Molecular Modeling and Structural Stability of Wild-Type and Mutant CYP51 from Leishmania major: In Vitro and In Silico Analysis of a Laboratory Strain
by: Masoud Keighobadi, et al.
Published: (2018-03-01)